These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27013382)

  • 1. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
    Taylor CJ; Thieroff-Ekerdt R; Shiff S; Magnus L; Fleming R; Gommoll C
    J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S
    J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis.
    Toskes PP; Secci A; Thieroff-Ekerdt R;
    Pancreas; 2011 Apr; 40(3):376-82. PubMed ID: 21343835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
    Graff GR; McNamara J; Royall J; Caras S; Forssmann K
    Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis.
    Wooldridge JL; Schaeffer D; Jacobs D; Thieroff-Ekerdt R
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):612-5. PubMed ID: 25050848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.
    Wooldridge JL; Heubi JE; Amaro-Galvez R; Boas SR; Blake KV; Nasr SZ; Chatfield B; McColley SA; Woo MS; Hardy KA; Kravitz RM; Straforini C; Anelli M; Lee C
    J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Strausbaugh SD; Woo MS; Tong SY; Silber SA; Mulberg AE; Leitz G
    J Cyst Fibros; 2011 Sep; 10(5):350-6. PubMed ID: 21632288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency.
    Caras S; Boyd D; Zipfel L; Sander-Struckmeier S
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
    van der Haak N; Boase J; Davidson G; Butler R; Miller M; Kaambwa B; Kritas S
    J Cyst Fibros; 2016 Sep; 15(5):669-74. PubMed ID: 27102891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
    Heubi JE; Schaeffer D; Ahrens RC; Sollo N; Strausbaugh S; Graff G; Jain R; Witte S; Forssmann K
    J Pediatr; 2016 Sep; 176():156-161.e1. PubMed ID: 27297209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Lenglinger J; Hädrich M
    Ther Umsch; 2016 Nov; 73(9):500-504. PubMed ID: 27805488
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
    Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
    Thorat V; Reddy N; Bhatia S; Bapaye A; Rajkumar JS; Kini DD; Kalla MM; Ramesh H
    Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
    Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of PERT endpoint on endogenous lipase activity.
    Gao WY; Mulberg AE
    Pancreas; 2014 Nov; 43(8):1232-8. PubMed ID: 25102439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreas and pancreatitis: Exocrine pancreatic insufficiency.
    Ramsey ML; Galante GJ
    Pediatr Pulmonol; 2024 Sep; 59 Suppl 1():S44-S52. PubMed ID: 39105352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.